Search results for "drug evaluation"

showing 10 items of 188 documents

Synthesis and preliminary biological evaluation of a new pyridocarbazole derivative covalently linked to a thymidine nucleoside as a potential target…

2003

The therapy of human cancer is one of the more pursued goals by medicinal chemistry research. Most of the compounds clinically used as a treatment owe their efficacy to their cytotoxic interaction (direct or indirect) with nuclear DNA. This interaction results in the inhibition of DNA synthesis and the degradation of nucleic strands. Ellipticine is a naturally occurring 6H-pyrido[4,3-b]carbazole alkaloid endowed with antitumor activity, and several ellipticine derivatives have been used in clinical trials. We previously reported some 1,4-dimethyl-9H-carbazole derivatives structurally related to ellipticine. The purpose of our research was to transform the pyridocarbazole in a prodrug so tha…

PyridonesCarbazolesDrug Evaluation PreclinicalAntineoplastic Agentschemistry.chemical_compoundDrug Delivery SystemsCell Line TumorDrug DiscoveryHumansCytotoxicitynucleoside analogueDNA synthesisBiological activityGeneral ChemistryGeneral MedicineProdrugorganic synthesisPyrimidine NucleosidesBiochemistrychemistryNucleic acidantitumour activityThymidineNucleosideDNAThymidineChemicalpharmaceutical bulletin
researchProduct

Predicting antitrichomonal activity: A computational screening using atom-based bilinear indices and experimental proofs

2006

Existing Trichomonas vaginalis therapies are out of reach for most trichomoniasis people in developing countries and, where available, they are limited by their toxicity (mainly in pregnant women) and their cost. New antitrichomonal agents are needed to combat emerging metronidazole-resistant trichomoniasis and reduce the side effects associated with currently available drugs. Toward this end, atom-based bilinear indices, a new TOMOCOMD-CARDD molecular descriptor, and linear discriminant analysis (LDA) were used to discover novel, potent, and non-toxic lead trichomonacidal chemicals. Two discriminant functions were obtained with the use of non-stochastic and stochastic atom-type bilinear in…

Quantitative structure–activity relationshipDatabases FactualMolecular modelStereochemistryClinical BiochemistryDrug Evaluation PreclinicalPharmaceutical ScienceAntitrichomonal AgentsLigandsBiochemistryCross-validationChemometricsStructure-Activity Relationshipchemistry.chemical_compoundArtificial IntelligencePredictive Value of TestsMolecular descriptorDrug DiscoveryTrichomonas vaginalisAnimalsCluster AnalysisComputer SimulationMolecular BiologyStochastic ProcessesOrganic ChemistryComputational BiologyReproducibility of ResultsLinear discriminant analysisAntitrichomonal agentchemistryData Interpretation StatisticalTopological indexLinear ModelsMolecular MedicineBiological systemAlgorithmsBioorganic & Medicinal Chemistry
researchProduct

Bond-based bilinear indices for computational discovery of novel trypanosomicidal drug-like compounds through virtual screening

2014

Two-dimensional bond-based bilinear indices and linear discriminant analysis are used in this report to perform a quantitative structure-activity relationship study to identify new trypanosomicidal compounds. A data set of 440 organic chemicals, 143 with antitrypanosomal activity and 297 having other clinical uses, is used to develop the theoretical models. Two discriminant models, computed using bond-based bilinear indices, are developed and both show accuracies higher than 86% for training and test sets. The stochastic model correctly indentifies nine out of eleven compounds of a set of organic chemicals obtained from our synthetic collaborators. The in vitro antitrypanosomal activity of …

Quantitative structure–activity relationshipStereochemistryTrypanosoma cruziDrug Evaluation PreclinicalQuantitative Structure-Activity RelationshipBilinear interpolationSet (abstract data type)MiceDrug DiscoveryIc50 valuesmedicineAnimalsCells CulturedPharmacologyStochastic ProcessesVirtual screeningDose-Response Relationship DrugMolecular StructureChemistryMacrophagesOrganic ChemistryDiscriminant AnalysisGeneral MedicineLinear discriminant analysisTrypanocidal AgentsDiscriminantBenznidazoleBiological systemmedicine.drugEuropean Journal of Medicinal Chemistry
researchProduct

Harmonization of QSAR Best Practices and Molecular Docking Provides an Efficient Virtual Screening Tool for Discovering New G-Quadruplex Ligands

2015

Telomeres and telomerase are key players in tumorogenesis. Among the various strategies proposed for telomerase inhibition or telomere uncapping, the stabilization of telomeric G-quadruplex (G4) structures is a very promising one. Additionally, G4 stabilizing ligands also act over tumors mediated by the alternative elongation of telomeres. Accordingly, the discovery of novel compounds able to act on telomeres and/or inhibit the telomerase enzyme by stabilizing DNA telomeric G4 structures as well as the development of approaches efficiently prioritizing such compounds constitute active areas of research in computational medicinal chemistry and anticancer drug discovery. In this direction, we…

Quantitative structure–activity relationshipTelomeraseGeneral Chemical EngineeringDrug Evaluation PreclinicalQuantitative Structure-Activity RelationshipComputational biologyLibrary and Information SciencesBiologyG-quadruplexCrystallography X-RayLigandsMolecular Docking Simulationchemistry.chemical_compoundDrug DiscoveryHumansCell ProliferationGeneticsVirtual screeningMolecular StructureDrug discoveryQSARGeneral ChemistryFibroblastsTelomereComputer Science ApplicationsTelomereG-QuadruplexesMolecular Docking SimulationchemistryAcridinesDNAHeLa Cells
researchProduct

In vitro antibacterial activity of endodontic sealers

2004

Summary Objectives To evaluate the antibacterial activity of four endodontic sealers: one epoxy resin sealer (AH Plus), two zinc oxide eugenol (ZOE)-based sealers (Endomethasone, Pulp Canal Sealer), and one sealer containing both ZOE and orthophenilphenol (Vcanalare). Methods A direct contact test (DCT) was performed. A 10 μl suspension of Enterococcus faecalis was placed on the test material 20 min, 24 h and 7 days after mixing. Bacteria were allowed to directly contact the sealers for 1 h at 37 °C. Bacterial growth was then spectrophotometrically measured every 30 min for 7 h, and again after 24 h as well. Results All freshly mixed sealers showed complete inhibition of bacterial growth. S…

Settore MED/07 - Microbiologia E Microbiologia ClinicaContact testTime FactorsMaterials scienceHydrocortisoneDentistryBacterial growthDexamethasoneEnterococcus faecalisRoot Canal Filling Materialschemistry.chemical_compoundSettore MED/28 - Malattie OdontostomatologicheFormaldehydeEnterococcus faecalisPulp canalGeneral DentistrybiologyEpoxy Resinsbusiness.industryEndodontic sealerbiology.organism_classificationAntimicrobialThymolIn vitroAnti-Bacterial AgentsDrug CombinationschemistryZinc oxide eugenolDirect contact testDrug EvaluationAntibacterial activityEnterococcus faecaliAntibacterial activitybusinessNuclear chemistryJournal of Dentistry
researchProduct

Sorafenib perpetuates cellular anti-cancer effector functions by modulating the cross talk between macrophages and natural killer cells.

2012

Alternatively polarized macrophages (Mϕ) shape the microenvironment of hepatocellular carcinoma (HCC) and temper anticancer immune responses. We investigated if sorafenib alters the HCC microenvironment by restoring classical macrophage polarization and triggering tumor-directed natural killer (NK) cell responses. In vivo experiments were conducted with sorafenib (25 mg/kg)-treated C57BL/6 wildtype as well as hepatitis B virus (HBV) and lymphotoxin transgenic mice with and without HCC. Monocyte-derived Mϕ or tumor-associated macrophages (TAM) isolated from HCC tissue were treated with sorafenib (0.07-5.0 μg/mL) and cocultured with autologous NK cells. Mϕ and NK cell activation was analyzed …

SorafenibNiacinamideCarcinoma Hepatocellularmedicine.medical_treatmentMacrophage polarizationDrug Evaluation PreclinicalAntineoplastic AgentsApoptosisBiologyMiceliver cancer; therapy; microenvironment; immunology; HCCmedicineAnimalsHumansneoplasmsHepatologyMacrophagesPhenylurea CompoundsLiver NeoplasmsDegranulationNF-kappa BInterleukinMacrophage ActivationSorafenibdigestive system diseasesKiller Cells NaturalMice Inbred C57BLCytokineLymphotoxinImmunologyCancer researchInterleukin 12CytokinesInterleukin 18medicine.drug
researchProduct

Simultaneous screening and quantification of aminoglycoside antibiotics in honey using mixed-mode liquid chromatography with quadrupole time-of-fligh…

2018

An analytical method based on liquid chromatography with quadrupole time-of-flight mass spectrometry has been developed for the simultaneous determination of six aminoglycoside antibiotics in honey. The sample pretreatment included extraction with aqueous trichloroacetic acid followed by solid-phase extraction on Strata-X polymeric reversed phase cartridges. Liquid chromatography separation was performed on an Obelisc R zwitterionic type mixed-mode column. An ionBooster™ heated electrospray source was used and showed enhanced ionization efficiency in comparison to a conventional electrospray source. The observed signal enhancement ranged from 3- (neomycin) to 16-fold (gentamicin C1). A data…

Spectrometry Mass Electrospray IonizationElectrosprayTime FactorsElectrospray ionizationDrug Evaluation PreclinicalFiltration and Separation02 engineering and technologyMass spectrometry01 natural sciencesMass SpectrometryAnalytical ChemistryIonizationChromatographyChemistry010401 analytical chemistryAminoglycosideExtraction (chemistry)HoneyRepeatability021001 nanoscience & nanotechnologyAnti-Bacterial Agents0104 chemical sciencesAminoglycosidesGentamicin C10210 nano-technologyChromatography LiquidJournal of Separation Science
researchProduct

A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studies

2011

The aim of the present work was to develop a new mathematical method for estimating the area under the curve (AUC) and its variability that could be applied in different preclinical experimental designs and amenable to be implemented in standard calculation worksheets. In order to assess the usefulness of the new approach, different experimental scenarios were studied and the results were compared with those obtained with commonly used software: WinNonlin® and Phoenix WinNonlin®. The results do not show statistical differences among the AUC values obtained by both procedures, but the new method appears to be a better estimator of the AUC standard error, measured as the coverage of 95% confi…

Statistics and ProbabilityComputer scienceDrug Evaluation PreclinicalAdministration Oralcomputer.software_genreSoftwareCiprofloxacinArea under curveVariance estimationAnimalsPharmacology (medical)Rats WistarPharmacologyModels Statisticalbusiness.industryDesign of experimentsEstimatorModels TheoreticalConfidence intervalRatsStandard errorResearch DesignArea Under CurveData miningbusinesscomputerSoftwarePharmaceutical Statistics
researchProduct

Multicellular tumor spheroids: an underestimated tool is catching up again.

2009

The present article highlights the rationale, potential and flexibility of tumor spheroid mono- and cocultures for implementation into state of the art anti-cancer therapy test platforms. Unlike classical monolayer-based models, spheroids strikingly mirror the 3D cellular context and therapeutically relevant pathophysiological gradients of in vivo tumors. Some concepts for standardization and automation of spheroid culturing, monitoring and analysis are discussed, and the challenges to define the most convenient analytical endpoints for therapy testing are outlined. The potential of spheroids to contribute to either the elimination of poor drug candidates at the pre-animal and pre-clinical …

Stromal cellCellDrug Evaluation PreclinicalBioengineeringNanotechnologyContext (language use)Computational biologyBiologyApplied Microbiology and BiotechnologyMiceCancer stem cellSpheroids CellularmedicineTumor Cells CulturedAnimalsHumansSpheroidGeneral MedicineMicrofluidic Analytical TechniquesCoculture TechniquesHigh-Throughput Screening AssaysMulticellular organismmedicine.anatomical_structureDrug developmentStem cellBiotechnologyJournal of biotechnology
researchProduct

IMMUNOGENICITY OF AN ACELLULAR PERTUSSIS VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN COMBINED WITH FILAMENTOUS HEMAGGLUTININ AND PERT…

1993

We studied the immunogenicity of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin (PT-9K/129G), filamentous haemagglutinin, and a 69-kilodalton protein, pertactin, in 30 children aged 12 to 24 months and in 80 infants aged 2 to 4 months. A significant increase of the neutralizing titer and of the titers against pertussis toxin, filamentous hemagglutinin, and pertactin, as determined by enzyme-linked immunosorbent assay, was achieved after three doses of vaccine in all the children; a significant increase of these antibody titers was obtained in 100%, 96.1%, 93.5%, and 98.7% of the infants, respectively.

Time FactorsFilamentous haemagglutinin adhesinPertussis toxincomplex mixturesBordetella pertussisMicrobiologyNeutralization TestsHumansMedicineVirulence Factors BordetellaAdhesins BacterialImmunization ScheduleWhooping coughPertussis VaccineAntigens Bacterialbusiness.industryImmunogenicitypertussisAntibody titerInfantmedicine.diseaseAntibodies BacterialVirologyVaccinationTiterHemagglutininsPertussis ToxinVaccines InactivatedChild PreschoolImmunoglobulin GPediatrics Perinatology and Child HealthDrug EvaluationPertactinbusinessVaccinepertussis; VaccineBacterial Outer Membrane Proteins
researchProduct